Enfusion
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $52,938 | $51,166 | $49,455 | $48,052 |
Gross Profit | 36,540 | 34,826 | 33,493 | 31,878 |
EBITDA | 1,584 | 5,821 | 5,576 | 1,561 |
EBIT | 2,861 | 2,703 | -1,113 | |
Net Income | 121 | 1,415 | 1,826 | -539 |
Net Change In Cash | 52,938 | 51,166 | 49,455 | 48,052 |
Free Cash Flow | 7,010 | 13,387 | 4,608 | -1,215 |
Cash | 54,480 | 48,299 | 34,447 | 32,894 |
Basic Shares | 129,558 | 128,984 | 128,852 | 89,509 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $201,611 | $174,535 | $150,349 | $111,700 |
Gross Profit | 136,737 | 116,894 | 103,249 | 79,855 |
EBITDA | 6,155 | 21,935 | -5,620 | -271,909 |
EBIT | 11,948 | -12,221 | -275,884 | |
Net Income | 2,823 | 6,025 | -13,263 | -282,242 |
Net Change In Cash | 201,611 | 174,535 | 150,349 | 111,700 |
Cost of Revenue | -1,734 | |||
Free Cash Flow | 31,047 | 15,963 | 6,225 | -8,332 |
Cash | 54,480 | 35,604 | 62,545 | 64,365 |
Basic Shares | 129,550 | 129,429 | 85,393 | 65,583 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.03 |
2024-09-30 | $0.05 |
2024-06-30 | $0.05 |
2024-03-31 | $0.06 |
